Received Jun 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) in a male patient of an unknown age who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain) (seriousness criterion hospitalization). At the time of the report, PAIN (Pain) had not resolved. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) was unknown. No concomitant medication was reported. The patient had been in constant pain for several years since receiving the vaccine, which had significantly affected his quality of life and the family's overall well-being. He was unable to participate in family activities and was often in a negative state due to his pain. It was unknown if the patient experienced any additional symptoms or events. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2026-797656 (E2B Linked Report).; Reporter's Comments: Company comment: The benefit-risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2026-797656:Patient (F-O)